Gabapentin for once-daily treatment of post-herpetic neuralgia: A review

Clinical Interventions in Aging

Volumn 7, Issue , 2012, Pages 249-255

  Beal, Benjamin ^a   Moeller Bertram, Tobias ^a,b   Schilling, Jan M ^a   Wallace, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Aging population; Gabapentin; Gabapentin extended release; Neuropathic pain; Post herpetic neuralgia

Indexed keywords

ANALGESIC AGENT; DULOXETINE; GABAPENTIN; LIDOCAINE; PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ATAXIA; BEDTIME DOSAGE; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG RELEASE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EVENING DOSAGE; EXTENDED DRUG RELEASE; FOOD AND DRUG ADMINISTRATION; GERIATRIC PATIENT; HUMAN; IMMEDIATE DRUG RELEASE; MORNING DOSAGE; NAUSEA; PAIN ASSESSMENT; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; REVIEW; SOMNOLENCE; TREATMENT DURATION; TREATMENT RESPONSE; AGED; DELAYED RELEASE FORMULATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGED; AMINES; ANALGESICS; CYCLOHEXANECARBOXYLIC ACIDS; DELAYED-ACTION PREPARATIONS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA, POSTHERPETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84871684090     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S23783     Document Type: Review

References (25)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959-1964.
2. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1-32.
3. Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage. 2004;28:396-411.
4. Lindsay TJ, Rodgers BC, Savath V, Hettinger K. Treating diabetic peripheral neuropathic pain. Am Fam Physician. 2010;82:151-158.
5. Doth AH, Hansson PT, Jensen MP, Taylor RS. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149:338-344.
6. Johnson RW. Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes. 2007;14 Suppl 2:30-34.
7. Bader MS, McKinsey DS. Viral infections in the elderly. The challenges of managing herpes zoster, influenza, and RSV. Postgrad Med. 2005;118:45-48.
8. Dworkin RH, Gnann JW, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9(1 Suppl 1):S37-S44.
9. Vander Straten M, Carrasco D, Lee P, Tyring SK. Reduction of postherpetic neuralgia in herpes zoster. J Cutan Med Surg. 2001;5:409-416.
10. Bouhassira D, Chassany O, Gaillat J, etal. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153:342-349.
11. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009;122(Suppl 10):S22-S32.
12. American Pain Foundation. Treatment options for post-herpetic neuralgia (long-term nerve pain). Available at: http://www.painfoundation.org/learn/pain-conditions/shingles/treatment-options-phn.html. Accessed on May 4, 2012.
13. Depomed Inc. Depomed announces US Food and Drug Administration approval of Gralise™ (gabapentin) once-daily tablets for treatment of post-herpetic neuralgia. Available at: http://investor.depomedinc.com/phoenix.zhtml?c=97276&p=irol-newsArticle_pf&ID=1521435. Accessed May 4, 2012.
14. Neurontin [package insert]. New York, NY: Pfizer Inc; 2009.
15. Singh D, Kennedy DH. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther. 2003;25:852-889.
16. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49:661-669.
17. Sang CN, Sathyanarayana R, Carter FJ, Sweeney M. Extended release for the once-daily treatment of post herpetic neuralgia. Poster presented at the International Association for the Study of Pain, 13th World Congress on Pain, August 29-September 2, 2010, Montreal, Canada.
18. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837-1842.
19. Gordi T, Hou E, Kasichayanula S, Berner B. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects. Clin Ther. 2008;30:909-916.
20. Rice AS, Maton S; Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 2001;94:215-224.
21. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia. JAMA. 1998;280:1837-1842.
22. Edelsberg JS, Lord C, Oster G. Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother. 2011;45:1483-1490.
23. Irving G, Jensen M, Cramer M, etal. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain. 2009;25:185-192.
24. 2-δligands on the efficacy and adverse event profile of once-daily gabapentin for the treatment of postherpetic neuralgia. Poster presented at the 63rd Annual Meeting of the American Academy of Neurology, April 9-16, 2011, Honolulu, HI.
25. Sweeney M, Sathyanarayana R. Efficacy and tolerability of once-daily gabapentin for the treatment of postherpetic neuralgia in patients at least 65 years old. Poster presented at the 34th Annual Meeting of the Society of General Internal Medicine, May 4-7, 2011, Phoenix, AZ.